Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Muhammed N Zahir"'
Autor:
Ali Aljubran, Mahmoud A Elshenawy, Magdy Kandil, Muhammed N Zahir, Ahmed Shaheen, Ahmed Gad, Omar Alshaer, Ahmed Alzahrani, Abdelmonem Eldali, Shouki Bazarbashi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Background: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local
Externí odkaz:
https://doaj.org/article/4b9c91c1f783485a9cbe8fefc50da313
Autor:
Muhammed N Zahir, Ahmed Shaheen, Ahmed Alzahrani, Mahmoud A. Elshenawy, Ali Aljubran, Abdelmonem Eldali, Omar Alshaer, Shouki Bazarbashi, Ahmed Gad, Magdy S. Kandil
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Background: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86913413739cd39b240707f29ac11986
https://doi.org/10.1093/annonc/mdy431.026
https://doi.org/10.1093/annonc/mdy431.026